FDA Says StemGenex Marketing of Unproven Stem Cell Treatment Is Illegal

November 19, 2018

(Los Angeles Times) – The Food and Drug Administration has come down hard on StemGenex, a La Jolla clinic pitching stem cell treatments for multiple sclerosis, diabetes, Parkinson’s and other conditions. In a warning letter made public Tuesday, the FDA says that StemGenex’s marketing is illegal, and that its manufacturing procedures are “putting patients at risk.” The agency also said that there’s no evidence that StemGenex followed up or investigated “multiple complaints involving possible adverse effects” of its treatments experienced by patients.